Synthesis of Findings, Current Investigations, and Future Directions: Operation Brain Trauma Therapy

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Neurotrauma

• Publication date

  2016-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/neu.2015.4133PMID 26671284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cited by this paper
• Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cited by this paper
• Erythropoietin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cited by this paper
• Simvastatin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cited by this paper
• Levetiracetam Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cited by this paper
• Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy

  2016cited by this paper
• Cyclosporine Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cited by this paper
• Emerging Therapies in Traumatic Brain Injury

  2015cited by this paper
• Pre-Clinical Traumatic Brain Injury Common Data Elements: Toward a Common Language Across Laboratories

  2015cited by this paper
• Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes

  2015cited by this paper
• Reproducibility in Science: Improving the Standard for Basic and Preclinical Research

  2015cited by this paper
• Classification of traumatic brain injury: past, present, and future.

  2015cited by this paper
• Cell-based therapy for pediatric traumatic brain injury: not (yet) an update to the traumatic brain injury guidelines.

  2015cited by this paper
• Biomarkers of Traumatic Injury Are Transported from Brain to Blood via the Glymphatic System

  2015cited by this paper
• Comment: Importance of cognitive reserve in traumatic brain injury

  2014cited by this paper
• Autologous Bone Marrow Mononuclear Cells Reduce Therapeutic Intensity for Severe Traumatic Brain Injury in Children*

  2014cited by this paper
• Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation.

  2014cited by this paper
• Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial.

  2014cited by this paper
• Very early administration of progesterone for acute traumatic brain injury.

  2014cited by this paper
• Translational research in acute central nervous system injury: lessons learned and the future.

  2014cited by this paper
• Amantadine Improves Cognitive Outcome and Increases Neuronal Survival after Fluid Percussion Traumatic Brain Injury in Rats

  2014cited by this paper
• Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward: Report of the Department of Defense Neurotrauma Pharmacology Workgroup

  2014cited by this paper
• Hemorrhagic Shock Shifts the Serum Cytokine Profile from Pro- to Anti-Inflammatory after Experimental Traumatic Brain Injury in Mice

  2014cited by this paper
• Minocycline plus N-acetylcysteine synergize to modulate inflammation and prevent cognitive and memory deficits in a rat model of mild traumatic brain injury.

  2013cited by this paper
• Severe Brief Pressure-Controlled Hemorrhagic Shock after Traumatic Brain Injury Exacerbates Functional Deficits and Long-Term Neuropathological Damage in Mice

  2012cited by this paper
• Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention

  2012cited by this paper
• RIGOR Guidelines: Escalating STAIR and STEPS for Effective Translational Research

  2012cited by this paper
• Translational spinal cord injury research: preclinical guidelines and challenges.

  2012cited by this paper
• Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model

  2012cited by this paper
• Low-Level Laser Light Therapy Improves Cognitive Deficits and Inhibits Microglial Activation after Controlled Cortical Impact in Mice

  2012cited by this paper
• Acute Minocycline Treatment Mitigates the Symptoms of Mild Blast-Induced Traumatic Brain Injury

  2012cited by this paper
• Drug development: Raise standards for preclinical cancer research

  2012cited by this paper
• Placebo-controlled trial of amantadine for severe traumatic brain injury.

  2012cited by this paper
• Blast Exposure in Rats with Body Shielding Is Characterized Primarily by Diffuse Axonal Injury

  2011cited by this paper
• Dilantin Therapy in an Experimental Model of Traumatic Brain Injury: Effects of Limited versus Daily Treatment on Neurological and Behavioral Recovery

  2011cited by this paper
• Critical appraisal of neuroprotection trials in head injury: What have we learned?

  2011cited by this paper
• Glibenclamide Is Superior to Decompressive Craniectomy in a Rat Model of Malignant Stroke

  2010cited by this paper
• Animal models of traumatic brain injury: is there an optimal model to reproduce human brain injury in the laboratory?

  2010cited by this paper
• Blast-Induced Brain Injury and Posttraumatic Hypotension and Hypoxemia

  2009cited by this paper
• Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke

  2009cited by this paper
• Classification of Traumatic Brain Injury for Targeted Therapies

  2008cited by this paper
• Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration.

  2007cited by this paper
• Nicotinamide Treatment Reduces Behavioral Impairments and Provides Cortical Protection after Fluid Percussion Injury in the Rat

  2006cited by this paper
• Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage

  2006cited by this paper
• Critical appraisal of neuroprotection trials in head injury: What have we learned?

  2004cited by this paper
• Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats

  2002cited by this paper
• The Simple Model Versus the Super Model: Translating Experimental Traumatic Brain Injury Research to the Bedside

  2001cited by this paper
• One-Year Study of Spatial Memory Performance, Brain Morphology, and Cholinergic Markers After Moderate Controlled Cortical Impact in Rats

  1999influential reference
• Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies.

  1999cited by this paper
• Amantadine improves water maze performance without affecting motor behavior following traumatic brain injury in rats

  1999cited by this paper
• Endogenous repair after spinal cord contusion injuries in the rat.

  1997cited by this paper
• MASCIS Evaluation of Open Field Locomotor Scores: Effects of Experience and Teamwork on Reliability

  1996cited by this paper
• A new model of diffuse brain injury in rats. Part II: Morphological characterization.

  1994cited by this paper

• Synaptamide regulates astroglial functional activity after cerebral cortex injury

  2025cites this paper
• Traumatic Brain Injury in the Long-COVID Era

  2024cites this paper
• Advances in neuroproteomics for neurotrauma: unraveling insights for personalized medicine and future prospects

  2023cites this paper
• Characterization of the lncRNA-miRNA-mRNA regulatory network to reveal potential functional competing endogenous RNAs in traumatic brain injury

  2023cites this paper
• Revert total protein normalization method offers a reliable loading control for mitochondrial samples following TBI.

  2023cites this paper
• Animal models and human tissue compared to better understand and treat the epilepsies

  2023cites this paper
• Comprehensive evaluation of mitochondrial redox profile, calcium dynamics, membrane integrity and apoptosis markers in a preclinical model of severe penetrating traumatic brain injury.

  2023cites this paper
• Glibenclamide for Brain Contusions: Contextualizing a Promising Clinical Trial Design that Leverages an Imaging-Based TBI Endotype

  2023cites this paper
• Advances in Traumatic Brain Injury Biomarkers

  2022cites this paper
• Developing a National Trauma Research Action Plan: Results from the Neurotrauma Research Panel Delphi Survey

  2022cites this paper
• High arterial oxygen levels and supplemental oxygen administration in traumatic brain injury: insights from CENTER-TBI and OzENTER-TBI

  2022cites this paper
• Exploring serum glycome patterns after moderate to severe traumatic brain injury: A prospective pilot study

  2022cites this paper
• Etifoxine Restores Mitochondrial Oxidative Phosphorylation and Improves Cognitive Recovery Following Traumatic Brain Injury

  2021cites this paper
• Rebuilding Microbiome for Mitigating Traumatic Brain Injury: Importance of Restructuring the Gut-Microbiome-Brain Axis

  2021cites this paper
• Omega-3 Fatty Acids and Vitamin D Decrease Plasma T-Tau, GFAP, and UCH-L1 in Experimental Traumatic Brain Injury

  2021cites this paper
• A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice

  2021cites this paper
• Operation Brain Trauma Therapy: An Exploratory Study of Levetiracetam Treatment Following Mild Traumatic Brain Injury in the Micro Pig

  2021cites this paper
• Kollidon VA64 Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2021cites this paper
• Babaodan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation.

  2020cites this paper
• Sarm1 loss reduces axonal damage and improves cognitive outcome after repetitive mild closed head injury.

  2020cites this paper
• Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence

  2020cites this paper
• Exploring the Application of a Multicenter Study Design in the Preclinical Phase of Translational Research

  2020cites this paper
• Circulating GFAP and Iba-1 levels are associated with pathophysiological sequelae in the thalamus in a pig model of mild TBI

  2020cites this paper
• Therapeutic target identification, validation and drug discovery for traumatic brain injury

  2020cites this paper
• Current State of the Art in Neurotrauma Research

  2020cites this paper
• Glibenclamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2020cites this paper
• Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh Vision

  2020cites this paper
• Developing Successful Neuroprotective Treatments for TBI: Translational Approaches, Novel Directions, Opportunities and Challenges

  2020cites this paper
• Gut Microbiota as a Therapeutic Target to Ameliorate the Biochemical, Neuroanatomical, and Behavioral Effects of Traumatic Brain Injuries

  2019cites this paper
• Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.

  2019cites this paper
• Interleukin-1 Receptor 1 Deletion in Focal and Diffuse Experimental Traumatic Brain Injury in Mice

  2019cites this paper
• Multicenter preclinical studies as an innovative method to enhance translation: a systematic review of published studies

  2019cites this paper
• Cortical Spreading Depression Denotes Concussion Injury

  2019influential citation
• Examining the neuroprotective efficacy of arginine-rich peptides in a traumatic brain injury model

  2019cites this paper
• Enduring Neuroprotective Effect of Subacute Neural Stem Cell Transplantation After Penetrating TBI

  2019cites this paper
• The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments

  2018cites this paper
• Operation Brain Trauma Therapy: 2016 Update.

  2018cites this paper
• Evaluation of taurine neuroprotection in aged rats with traumatic brain injury

  2018cites this paper
• Conference Report: 6th Annual International Symposium on Regenerative Rehabilitation.

  2018cites this paper
• Pre-Clinical Testing of Therapies for Traumatic Brain Injury

  2018influential citation
• Severe Traumatic Brain Injury

  2018cites this paper
• Preclinical Models of Traumatic Brain Injury: Emerging Role of Glutamate in the Pathophysiology of Depression

  2018cites this paper
• Multi-Center Pre-clinical Consortia to Enhance Translation of Therapies and Biomarkers for Traumatic Brain Injury: Operation Brain Trauma Therapy and Beyond

  2018cites this paper
• Controversies in Severe Traumatic Brain Injury Management

  2018cites this paper
• The case for introducing pre-registered confirmatory pharmacological pre-clinical studies

  2018cites this paper
• Clinical Trials for Traumatic Brain Injury: Designs and Challenges

  2018cites this paper
• Adding insight to injury: a new era in neurotrauma.

  2017cites this paper
• Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides

  2017cites this paper
• Traumatic Brain Injury Advances.

  2017cites this paper
• ‘Spreading depression of Leão’ and its emerging relevance to acute brain injury in humans

  2017cites this paper
• Pre-clinical models in pediatric traumatic brain injury—challenges and lessons learned

  2017cites this paper
• Severe traumatic brain injury: targeted management in the intensive care unit.

  2017cites this paper
• Inhibiting Axon Degeneration in a Mouse Model of Acute Brain Injury Through Deletion of Sarm1

  2017cites this paper
• Translational obstacles with off-label drug use in acute traumatic brain injury

  2017cites this paper
• Clinical Utility of Blood-Based Protein Biomarkers in Traumatic Brain Injury

  2017cites this paper
• Titrating the Dose of Oxygen after Severe Traumatic Brain Injury in the Era of Precision Medicine

  2017cites this paper
• Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside Neuroprotection

  2017cites this paper
• Effects of the dimeric PSD‐95 inhibitor UCCB01–144 on functional recovery after fimbria‐fornix transection in rats

  2017cites this paper
• Treatment options for severe traumatic brain injuries in children: current therapies, challenges, and future prospects

  2017cites this paper
• Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy

  2016cites this paper
• Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cites this paper
• Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cites this paper
• Cyclosporine Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

  2016cites this paper
• Theme: Integrating Microdialysis and Imaging Tools in Systems Pharmacology Microdialysis Monitoring in Clinical Traumatic Brain Injury and Its Role in Neuroprotective Drug Development

  year unknowncites this paper